Literature DB >> 36261785

Case report long segment myelitis secondary to neuro melioidosis.

Sahathevan Vithoosan1, Asha Kumarasiri2, Nadun Madushanka Vithanage2, Bimsara Senanayake2.   

Abstract

BACKGROUND: Neuro-melioidosis, comprising 4% of all cases of melioidosis carries a risk of high morbidity and mortality. We describe two Sri Lankan patients presenting with long segment myelitis secondary to melioidosis. CASE
PRESENTATION: Case 1: 47-year-old male presented with right side hemiparesis which progressed rapidly to quadriparesis. Initial cerebro spinal fluid (CSF) analysis revealed protein 76 mg/dl and glucose 72 mg/dl but without a cellular reaction. MRI spine revealed long segment myelitis with contrast enhancement. The patient was treated with intravenous methyl prednisolone pulses (IV MPP) and plasma exchanges(PLEX) on suspicion of an immune mediated myelitis but without success. A repeat MRI revealed high signal changes in the brain stem and along the entire spinal cord with contrast enhancement. MRI brain after treatment with MPP/PLEX showed enhancing hyper intensities along the corticospinal tracts. The repeat CSF revealed protein 1187 mg/dl, glucose 78 mg/dl, lymphocytes 1600/mm3 and neutrophils 10,200/mm3. CSF culture has become positive for Burkholderia pseudomallei. Serum melioidosis antibody titre was 1: 320. He was started on IV meropenem with oral cotrimoxazole for 12 weeks followed by oral co trimoxazole. But he had poor clinical recovery. Case 2: 47-year-old female presented with bilateral lower limb weakness for 1-week duration. On examination, she had flaccid paraparesis with a sensory level at T11. Inflammatory markers were elevated. CSF analysis revealed protein 50 mg/dl with lymphocytes 172/mm3. MRI pan spine revealed a long segment myelitis. Serum melioidosis antibody titre was 1: 640. She was treated with IV meropenem for 8 weeks followed by oral co-trimoxazole with an excellent clinical and radiological response.
CONCLUSION: Numerous neurological manifestations have been described with melioidosis, however long segment myelitis with a positive CSF culture is not yet reported. These cases signify the importance of considering melioidosis as a differential in patients with long segment myelitis especially in endemic areas.
© 2022. The Author(s).

Entities:  

Keywords:  Burkholderia pseudomallei; Long segment myelitis; Melioidosis

Mesh:

Substances:

Year:  2022        PMID: 36261785      PMCID: PMC9580144          DOI: 10.1186/s12883-022-02917-6

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.903


  10 in total

1.  Melioidosis: a report of ten cases.

Authors:  R N Thin; M Brown; J B Stewart; C J Garrett
Journal:  Q J Med       Date:  1970-01

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Neurological melioidosis.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

4.  Risk factors for melioidosis and bacteremic melioidosis.

Authors:  Y Suputtamongkol; W Chaowagul; P Chetchotisakd; N Lertpatanasuwun; S Intaranongpai; T Ruchutrakool; D Budhsarawong; P Mootsikapun; V Wuthiekanun; N Teerawatasook; A Lulitanond
Journal:  Clin Infect Dis       Date:  1999-08       Impact factor: 9.079

5.  Cerebral melioidosis in Singapore: a review of five cases.

Authors:  D R Chadwick; B Ang; Y Y Sitoh; C C Lee
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 Jan-Feb       Impact factor: 2.184

6.  Neuromelioidosis: Craniospinal MRI Findings in Burkholderia pseudomallei Infection.

Authors:  C C Hsu; Dalveer Singh; Gigi Kwan; Martin Deuble; Chloe Aquilina; Ipeson Korah; Robert Norton
Journal:  J Neuroimaging       Date:  2015-08-10       Impact factor: 2.486

7.  Melioidosis and bilateral third-nerve palsies.

Authors:  R W Beck; R S Janssen; M L Smiley; N J Schatz; P J Savino; D H Rubin
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

Review 8.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

Review 9.  Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature.

Authors:  Katherine B Gibney; Allen C Cheng; Bart J Currie
Journal:  Clin Infect Dis       Date:  2008-09-01       Impact factor: 9.079

10.  Adenosine Deaminase Levels in CSF of Tuberculous Meningitis Patients.

Authors:  Bharat Kumar Gupta; Anchit Bharat; Bandyopadhyay Debapriya; Haren Baruah
Journal:  J Clin Med Res       Date:  2010-10-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.